Robyn M. Scherber, MD, MPH | Authors

Articles

Addressing Ruxolitinib Resistance in Myelofibrosis

September 13, 2018

Robyn M. Scherber, MD, MPH, physician, The Mays Cancer Center, the newly named center of UT Health San Antonio MD Anderson Cancer Center, addresses the management of patients with myelofibrosis after failure on ruxolitinib (Jakafi).